Treatment-Related Diarrhea in Patients With Cancer

被引:16
|
作者
Shaw, Colleen [1 ]
Taylor, Loryn [2 ]
机构
[1] Florida Canc Specialists, Tampa, FL USA
[2] Tampa Gen Hosp, Tampa, FL 33606 USA
关键词
IRINOTECAN-INDUCED DIARRHEA; DOUBLE-BLIND; CHEMOTHERAPY; RADIOTHERAPY; PROPHYLAXIS; PREVENTION; PROBIOTICS; NEOMYCIN; PLACEBO;
D O I
10.1188/12.CJON.413-417
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diarrhea caused by chemotherapy or radiation in patients with cancer can cause dehydration, electrolyte imbalance, malnutrition, fluid depletion, and hospitalization. In severe cases, uncontrolled diarrhea can lead to therapy dose reductions or even death. Oncology professionals may simply assess for the absence or presence of diarrhea, rather than using a standard assessment tool; they also may lack awareness regarding availability of established assessment and treatment guidelines. However, use of treatment guidelines can lead to optimal prevention and management of treatment-induced diarrhea in patients with cancer. Oncology nurses play a key role in the identification and treatment of chemotherapy- and radiation therapy-induced diarrhea.
引用
收藏
页码:413 / 417
页数:5
相关论文
共 50 条
  • [21] Cancer treatment-related cardiac dysfunction
    Brady, Bernadette
    Murphy, Ross
    [J]. BMJ SUPPORTIVE & PALLIATIVE CARE, 2023, 13 (01) : 53 - 56
  • [22] Cancer Treatment-Related Lymphedema in Geriatrics
    Mondry, Tammy E.
    Mondry, Joseph M.
    Soballe, Peter W.
    [J]. TOPICS IN GERIATRIC REHABILITATION, 2011, 27 (03) : 215 - 221
  • [23] Cancer treatment-related gastrointestinal symptoms
    Bowen, Joanne M.
    [J]. CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2017, 11 (02) : 118 - 119
  • [24] Cancer treatment-related neurological toxicity
    Legriel, S.
    Azoulay, E.
    [J]. REANIMATION, 2012, 21 (05): : 613 - 624
  • [25] Bevacizumab and Cancer Treatment-Related Mortality
    Cerrito, Patricia B.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2292 - 2292
  • [26] Severe Treatment-Related Lymphopenia in Patients with Newly Diagnosed Rectal Cancer
    Campian, Jian L.
    Ye, Xiaobu
    Sarai, Guneet
    Herman, Joseph
    Grossman, Stuart A.
    [J]. CANCER INVESTIGATION, 2018, 36 (06) : 356 - 361
  • [27] Treatment-related mortality with aflibercept in cancer patients: a meta-analysis
    Qi, Wei-Xiang
    Tang, Li-Na
    Shen, Zan
    Yao, Yang
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (04) : 461 - 467
  • [28] Incidence of treatment-related toxicities in head and neck cancer Medicare patients
    McLaurin, KK
    Ciesla, G
    Kamimoto, PA
    Chico, I
    Apostolaros, M
    Leader, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 739S - 739S
  • [29] Assessment of treatment-related thyroid dysfunction in patients with head and neck cancer
    Cetinayak, Oguz
    Akman, Fadime
    Kentli, Suleyman
    Duzen, Murat
    Eyiler, Ferhat
    Sen, Mehme
    Kinay, Munir
    [J]. TUMORI, 2008, 94 (01) : 19 - 23
  • [30] Treatment-Related Mortality With Bevacizumab in Cancer Patients A Meta-analysis
    Ranpura, Vishal
    Hapani, Sanjaykumar
    Wu, Shenhong
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (05): : 487 - 494